Anatomical and Pathological Observation and Analysis of SARS and COVID-19: Microthrombosis Is the Main Cause of Death

• Published in: Biological procedures online 2021-01, Vol.23 (1), p.4-4, Article 4
• Main Authors: Chen, Wenjing, Pan, Jing Ye
• Format: Article
• Language: English
• Subjects: Alveoli; Analysis; Atrophy; Autopsy; Blood clot; Cellulose; Coronaviruses; COVID-19; Death; Degradation products; Diffuse Alveolar Damage; Disease transmission; Disseminated intravascular coagulation; Edema; Fibrin; Fibrinogen; Fibrinolysis; Health aspects; Hypoxemia; Infections; Inflammation; Leukocytes (neutrophilic); Liver; Lungs; Lymphatic system; Lymphocytes; Medical research; Medicine, Experimental; Membrane permeability; Microcirculation Dysfunction; Microvasculature; Mortality; Pathogenesis; Pathology; Patients; Perfusion; Permeability; Pulmonary arteries; Pulmonary fibrosis; Respiratory distress syndrome; Review; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Spleen; Thrombosis; Tissue factor
• ISSN: 1480-9222; 1480-9222
• DOI: 10.1186/s12575-021-00142-y

The spread of the coronavirus (SARS-CoV-2, COVID-19 for short) has caused a large number of deaths around the world. We summarized the data reported in the past few months and emphasized that the main causes of death of COVID-19 patients are DAD (Diffuse Alveolar Damage) and DIC (Disseminated intravascular coagulation). Microthrombosis is a prominent clinical feature of COVID-19, and 91.3% of dead patients had microthrombosis.Endothelial damage caused by SARS-CoV-2 cell invasion and subsequent host response disorders involving inflammation and coagulation pathways play a key role in the progression of severe COVID-19. Microvascular thrombosis may lead to microcirculation disorders and multiple organ failure lead to death.The characteristic pathological changes of DAD include alveolar epithelial and vascular endothelial injury, increased alveolar membrane permeability, large numbers of neutrophil infiltration, alveolar hyaline membrane formation, and hypoxemia and respiratory distress as the main clinical manifestations. DAD leads to ARDS in COVID-19 patients. DIC is a syndrome characterized by the activation of systemic intravascular coagulation, which leads to extensive fibrin deposition in the blood. Its occurrence and development begin with the expression of tissue factor and interact with physiological anticoagulation pathways. The down-regulation of fibrin and the impaired fibrinolysis together lead to extensive fibrin deposition.DIC is described as a decrease in the number of platelets and an increase in fibrin degradation products, such as D-dimer and low fibrinogen. The formation of microthrombus leads to the disturbance of microcirculation, which in turn leads to the death of the patient. However, the best prevention and treatment of COVID-19 microthrombosis is still uncertain.This review discusses the latest findings of basic and clinical research on COVID-19-related microthrombosis, and then we proposed the theory of microcirculation perfusion bundle therapy to explore effective methods for preventing and treating COVID-19-related microthrombosis. Further research is urgently needed to clarify how SARS-CoV-2 infection causes thrombotic complications, and how it affects the course and severity of the disease. To cultivate a more comprehensive understanding of the underlying mechanism of this disease. Raise awareness of the importance of preventing and treating microthrombosis in patients with COVID-19.